SCHEMBL31061634

SCHEMBL31061634

COc1cc2sc(-c3c(-c4ccccc4F)n[nH]c3N)nc2cc1F

nearest known ligand 0.72

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ILK Q13418 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL686446 1.00 ILK (0.72) ILK
SCHEMBL686631 0.89 ILK (0.71) ILK
SCHEMBL687297 0.87 ILK (0.75) ILK
SCHEMBL686429 0.84 ILK (0.71) ILK
SCHEMBL686470 0.84 ILK (0.73) ILK
SCHEMBL686901 0.84 ILK (0.73) ILK
SCHEMBL687044 0.84 ILK (0.72) ILK
SCHEMBL686892 0.84 ILK (0.73) ILK
SCHEMBL687319 0.83 ILK (0.73) ILK
SCHEMBL692653 0.83 ILK (0.72) ILK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed